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Abstract
A case study of 39-year old man with persistent wheezing, episodes of haemoptysis and dry cough
unsuccessfully treated with inhaled beta2-agonists and steroids for about 10 months. Chest
radiograph revealed a disproportion in dimensions between both lungs, with the left one being
smaller than the right one. Spirometry demonstrated a restrictive pattern. During bronchoscopy,
a polypoid endobronchial tumor, localized in the left main bronchus, completely occluding its
lumen, was found. The tumor was diagnosed as carcinoid. In this case, due to the lack of
characteristic symptoms, diagnosis of carcinoid was delayed. Patients unsuccessfully treated for
bronchial asthma or chronic obstructive pulmonary disease should undergo bronchoscopic
examination.
Case presentation
A 39-year-old white man, working as a house builder, was
admitted to our pulmonary ward in August 2007 with an
eleven-month history of persistent wheezing, heard not
only during auscultation but also by patient himself. This
wheezing had no correlation with physical exertion. He
also reported a few episodes of haemoptysis within last 7
months and dry cough for about a month. Patient's
weight was 81.5 kg, his height was 180 cm. Except from
nodular goitre (in euthyreosis), the patient reported no
other complaints or diseases in his medical history. His
family history was not clinically significant. He had a 10
pack-years smoking history, until the age of 31 when he
stopped smoking. He drank alcohol occasionally. His
symptoms were unsuccessfully treated with inhaled β2-
agonists and steroids for about 10 months. Apart from
these medications, he took no other drugs. On ausculta-
tion, there were wheezes in upper fields of both lungs. The
chest radiograph (figure 1) showed a disproportion in
dimensions and vascular markings between both lungs-
the left one was significantly smaller and had decreased
vascular markings in comparison to the right one- these
findings might be the expression of left lung hypoplasia.
The heart silhouette was discretely displaced to the left
side.
Spirometry performed during hospitalization in our clinic
showed a restrictive pattern (figure 2) with forced expira-
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tory volume in one second (FEV1) of 59% predicted and
forced vital capacity (FVC) of 66% predicted. The FEV1/
FVC ratio was 70% predicted.
Bronchoscopy was performed, revealing a polypoid endo-
bronchial tumor, localized in the left main bronchus (2
cm from tracheal bifurcation), completely occluding its
lumen. The tumor was biopsied and the specimen was
sent to histological examination which gave the diagnosis
of bronchial carcinoid.
Thoracic computed tomography showed a polypoid mass
in the left main bronchus with a diameter of about 20
mm. The tumor showed very high enhancement after con-
trast medium administration: from 9 HU (Hounsfield
units) (figure 3a) to 119 HU in arterial phase (figure 3b)
and 47 HU in parenchymal phase (figure 3c), which is
characteristic for carcinoid.
Hilar and mediastinal nodes were not enlarged. In virtual
bronchoscopy, as well as in transparent reconstruction of
the airways, a total occlusion of the left main bronchus by
the tumor could be observed (Figure 4 and 5).
The patient was transferred to thoracic surgery ward for
surgical treatment. He underwent left pulmonectomy and
histopathological analysis of post-operative material con-
firmed the diagnosis of bronchial carcinoid. There were
no complications during post-operative period and the
patient was discharged from hospital 10 days after the
operation. Then, the patient went abroad and was lost for
follow-up until May 2008. On control visit in May, he was
in very good condition, presenting no signs of pulmonary
disease. On physical examination, except from dimin-
ished breath sounds and dullness to percussion over left
lung (due to pulmonectomy and consequent pleural fluid
accumulation) no abnormalities were found. In control
computed tomography there were no signs of recurrence
of the disease.
Discussion
Pulmonary carcinoids comprise 1-2% of all lung tumors.
They may develop in many locations in the body but most
often, they are found in small intestine (26%), respiratory
system (25%) and appendix (19%) [1].
Carcinoid tumors are classified as typical or atypical
according to histopathological criteria. This division has a
strict extrapolation to survival rates: in case of typical pul-
monary carcinoids 5-year survival rate is over 90%, in
atypical ones- it is within the range of 40-60% [2].
Chest radiograph performed at admission to the hospital Figure 1
Chest radiograph performed at admission to the hos-
pital.
Flow-volume curve showing a restrictive pattern performed  at admission to the hospital Figure 2
Flow-volume curve showing a restrictive pattern per-
formed at admission to the hospital.Cases Journal 2008, 2:7414 http://www.casesjournal.com/content/2/1/7414
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High enhancement of the tumor (arrow) after contrast medium administration: on the left- before administration of contrast  medium, in the middle-after administration; arterial phase, on the right-parenchymal phase Figure 3
High enhancement of the tumor (arrow) after contrast medium administration: on the left- before administra-
tion of contrast medium, in the middle-after administration; arterial phase, on the right-parenchymal phase.
Total occlusion of the left main bronchus by the tumor  (arrow) Figure 4
Total occlusion of the left main bronchus by the 
tumor (arrow).
Amputation of the left main bronchus by the tumor (arrow) Figure 5
Amputation of the left main bronchus by the tumor 
(arrow).Cases Journal 2008, 2:7414 http://www.casesjournal.com/content/2/1/7414
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The following symptoms are observed most often in
patients with carcinoid localized in respiratory system:
haemoptysis, cough, recurrent pulmonary infections,
fever, chest discomfort, unilateral wheezing and shortness
of breath [3].
Due to the lack of characteristic symptoms, diagnosis of
pulmonary carcinoid is delayed and patients are often
misdiagnosed with asthma or chronic obstructive pulmo-
nary disease. According to three studies, there is an aver-
age delay of, respectively, 19, 13 and 10 months from the
first symptoms to the final diagnosis of carcinoid [4-6].
Although general prognosis for patients with this neo-
plasm is quite favorable, it is obvious that the earlier diag-
nosis is made, the chances for radical treatment increase.
As the majority of pulmonary carcinoids (70%) are
located in the main or lobar bronchi [7], they are within
the reach of a bronchoscope. According to British Thoracic
Society, flexible bronchoscopy is a safe procedure and
there are no controlled studies concerning the factors dis-
qualifying a patient from it [8]. Bronchoscopy cannot
replace computed tomography, these both procedures are
complementary, but to be able to orientate the treatment
and prognosis, we have to know the histopathological
Immunohistochemical staining positive for chromogranine A Figure 8
Immunohistochemical staining positive for chrom-
ogranine A.
Microscopic imaging of bronchial carcinoid (hematoxylin and  eosin staining) Figure 7
Microscopic imaging of bronchial carcinoid (hema-
toxylin and eosin staining).
Microscopic imaging of bronchial carcinoid (hematoxylin and  eosin staining) Figure 6
Microscopic imaging of bronchial carcinoid (hema-
toxylin and eosin staining).
Immunohistochemical staining positive for synaptophysin Figure 9
Immunohistochemical staining positive for synapto-
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diagnosis and the specimens for examination can be eas-
ily and safely provided by bronchoscopy.
Conclusion
This case is a good example of misdiagnosis of the disease.
Extended clinical diagnosis, including computed tomog-
raphy and bronchoscopy, should be considered in all
cases of bronchial asthma or chronic obstructive pulmo-
nary disease which do not respond to standard treatment.
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